:FDA

Shi-Nan Wu1, Xiao-Dong Chen1, Qing-He Zhang2

  • 1Xiamen University Affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.

概括

这项研究确定了17种药物显著增加与药物相关的角质炎的风险,而非眼科药物显示出更快的发病. 早期识别这些药物风险对于预防至关重要.